Effects of paclitaxel combined with carboplatin on expression of VEGF and tumor markers in ovarian cancer
10.16352/j.issn.1001-6325.2023.12.1861
- VernacularTitle:紫杉醇联合卡铂化疗对卵巢癌VEGF及肿瘤标志物表达的影响
- Author:
Shufen TAN
1
;
Xielan YANG
;
Linlin YANG
;
Shuqing LI
Author Information
1. 昆明医科大学第三附属医院 妇科,云南 昆明 650118
- Keywords:
ovarian cancer;
combined chemotherapy;
blood cells;
VEGF;
tumor marker
- From:
Basic & Clinical Medicine
2023;43(12):1861-1865
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effect of paclitaxel with carboplatin combined chemotherapy on hemocyte re-lated indexes,vascular endothelial growth factor(VEGF)and tumor markers in ovarian cancer(OC)patients.Methods OC patients combined chemotherapy(CC)group and ovarian benign tumor control group with 50 cases in each.The pathological changes in the ovarian cells were observed by HE staining and the expression of VEGF was observed by immunohistochemical staining(IHC).Blood cell was counted by flow cytometry(FC).Serum car-bohydrate antigen 125(CA125)and human epididymal protein 4(HE4)were measured by electrochemical lumi-nescence(ECL).Results Compared with control group,the ovarian tissue structure was disordered and the cell atypia was obvious in OC.VEGF expression was significantly enhanced.Platelet count(PLT),CA125 and HE4 were significantly increased(P＜0.01).However,necrotic cells were observed in ovarian tissue of CC group.VEGF expression was inhibited.PLT count and the level of CA125 and HE4 were significantly lower than those of control group after chemotherapy(P＜0.01).Conclusions Combined chemotherapy may regulate the level of VEGF,CA125 and HE4 in OC patients.
